Following major recalls of Chinese-manufactured medication that contained carcinogenic ingredients, lawmakers expressed their alarm, and sometimes disbelief, at the FDA's inability to regulate foreign suppliers at a Tuesday hearing.
Following major recalls of Chinese-manufactured medication that contained carcinogenic ingredients, Congress is taking a hard look at the U.S. supply chain of generic drugs.
"There's a hidden health crisis in this country that will affect us all," Rep. Anna Eshoo of California, chair of the Health Subcommittee, said in the hearing."The crippling inadequacy of the American drug supply."shortagesIndeed, in the past two years alone, the FDA has recalled three blood pressure drugs and the heartburn medication Zantac after they were found to contain potentially carcinogenic impurities that their Chinese manufacturer failed to report.
While the FDA maintains a"catalog" of foreign manufacturers, the sites are not required to tell the FDA whether they actually make APIs and in what quantities, according to Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Exclusive: J&J's own expert, working for FDA, found asbestos in Baby PowderEXCLUSIVE: Ever since J&J disclosed that a government test found asbestos in its Baby Powder, the company has attacked the validity of the result. In challenging the FDA’s finding, however, the healthcare giant is casting doubt on one of its own experts
Read more »
FDA approves new breakthrough therapy for cystic fibrosisWe are excited about this new therapy for CF. By maximizing detection across ethnicities for serious heritable conditions like CF, Foresight helps couples identify risk early so they can plan and prepare. Learn more about Foresight:
Read more »
Calm down, doggy. FDA approves generic drug for separation anxietyThe medication is for pups who fear being left alone.
Read more »
U.S. telecoms supply chain rules, seen hitting Huawei, under review: officialRules to implement a White House executive order that is expected to pave the wa...
Read more »